Plant sterol levels during cholesterol-lowering therapy
Not Applicable
- Conditions
- Cornary Heart Dsease with Hyperlipidemia
- Registration Number
- JPRN-UMIN000003346
- Lead Sponsor
- Kanazawa Medical University Department of Cardiology
- Brief Summary
In ezetimibe combination group, LDLC lowering respnoses were associated with the levels of cholesterol absorption markers before randomization. Contraly, those were associated with the level of cholesterol synthesis marker in atrovastatin doubling group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersenstivity Patient who has received it within four weeks undertaking administering of medicine Resin/Fibrate/Niacin/EPA/ Probucol etc Patient who judged that examination doctor in charge is improper
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method